Abstract
EWS/FLI1, a fusion gene found in Ewing's sarcoma, encodes a transcriptional regulator and promotes cellular transformation by modulating the transcription of specific target genes. We have found that EWS/FLI1 and structurally related fusion proteins upregulate manic fringe (MFNG), a recently described member of the Fringe gene family instrumental in somatic development. MFNG is also expressed in human tumour-derived cell lines expressing EWS/FLI1. Overexpression of MFNG in NIH 3T3 cells renders them tumorigenic in mice with severe combined immunodeficiency disease (SCID). These data demonstrate that part of the oncogenic effect of EWS/FLI1 is to transcriptionally deregulate a member of a family of morphogenic genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Delattre, O. et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162–165 (1992).
Ohno, T., Rao, V.N. & Reddy, E.S. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 53, 5859–5863 (1993).
Mao, X., Miesfeldt, S., Yang, H., Leiden, J.M. & Thompson, C.B. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J. Biol. Chem. 269, 18216–18222 (1994).
May, W.A. et al. Ewing sarcoma 11;22 translocation produces a chimeric factor that requires the DNA-binding domain encoded by FLU for transformation. Proc. Natl. Acad. Sci. USA 90, 5752–5756 (1993).
May, W.A. et al. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13, 7393–7398 (1993).
Lessnick, S.L., Braun, B.S., Denny, C.T. & May, W.A. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene. 10, 423–431 (1995).
Bailly, R.A. et al. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol. 14, 3230–3241 (1994).
Bonin, G., Scamps, C., Turc-Carel, C. & Lipinski, M. Chimeric EWS-FLI1 transcript in a Ewing Cell line with a complex t(11;22;14) translocation. Cancer Res. 53, 3655–3657 (1993).
Johnston, S.H. et al. A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development 124, 2245–2254 (1997).
Cohen, B. et al. Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila. Nature. Genet. 16, 283–288 (1997).
Sorensen, P.M.B. et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature. Genet. 6, 146–151 (1994).
Sorensen, P.M. et al. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diagn. Mol. Pathol. 2, 147–157 (1993).
Whang-Peng, J. et al. Cytogenetic characterization of selected small round Cell tumors of childhood. Cancer Genet. Cytogenet. 21, 185–208 (1986).
Yuan, Y.P., Schultz, J., Mlodzik, M. & Bork, P. Secreted fringe-like signaling molecules may be glycosyltransferases. Cell. 88, 9–11 (1997).
Irvine, K.D. & Wieschaus, E. fringe, a boundary-specific signaling molecule, mediates interactions between dorsal and ventral cell.s during Drosophila wing development. Cell. 79, 595–606 (1994).
Laufer, E. et al. Expression of Radical fringe in limb-bud ectoderm regulates apical ectodermal ridge formation. Nature. 386, 366–373 (1997).
Rodriguez-Esteban, C. et al. Radical fringe positions the apical ectodermal ridge at the dorsoventral boundary of the vertebrate limb. Nature. 386, 360–366 (1997).
Kim, J., Irvine, K.D. & Carroll, S.B. Cell recognition, signal induction, and symmetrical gene activation at the dorsal-ventral boundary of the developing Drosophila wing. Cell. 82, 795–802 (1995).
Uyttendaele, H. et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell.-specific mammalian Notch gene. Development. 122, 2251–2259 (1996).
Rohn, J.L., Lauring, A.S., Linenberger, M.L. & Overbaugh, J. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma. J. Virol. 70, 8071–8080 (1996).
Ellisen, L.W. et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 66, 649–661 (1991).
Pear, W.S. et al. Exclusive development of T Cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183, 2283–2291 (1996).
Guan, E. et al. T cell leukemia-associated human Notch/translocation–associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor–kappa B proteins in T cells. J. Exp. Med. 183, 2025–2032 (1996).
Look, A.T. Oncogenic role of “aster” transcription factors in human leukemias and sarcomas: a developmental model. Adv. Cancer Res. 67, 25–57 (1995).
Braun, B.S., Frieden, R., Lessnick, S.L., May, W.A. & Denny, C.T. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol.Cell.Biol. 15, 4623–4630 (1995).
Hubank, M. & Schatz, D.G. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22, 5640–5648 (1994).
Fu, X. & Kamps, M.P. E2a-Pbx1 induces aberrant expression of tissue-specif ic and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol.Cell.Biol. 17, 1503–1512 (1997).
Thompson, A.D. et al. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI-1 fusion. Oncogene 13, 2649–2658 (1996).
Dorit, R.L. & Ohara, O. . in Molecular Biology, Vol. 2(eds Ausubel, F.M. et al)15.6.1–15.6.10 (John Wiley & Sons, New York, 1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
May, W., Arvand, A., Thompson, A. et al. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat Genet 17, 495–497 (1997). https://doi.org/10.1038/ng1297-495
Issue Date:
DOI: https://doi.org/10.1038/ng1297-495
This article is cited by
-
MFNG is an independent prognostic marker for osteosarcoma
European Journal of Medical Research (2023)
-
A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing’s sarcoma cells, interacts with the EWS-FLI1 and partner proteins
Scientific Reports (2017)
-
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS–FLI1 fusion transcript
Cancer Chemotherapy and Pharmacology (2017)
-
Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours
Clinical Sarcoma Research (2012)
-
Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker
Tumor Biology (2012)